{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:57:47Z","timestamp":1793969867354,"version":"4.8.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1,1]]},"DOI":"10.1093\/ndt\/gfw353","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T12:08:24Z","timestamp":1486123704000},"page":"i115-i122","source":"Crossref","is-referenced-by-count":27,"title":["Cost-effectiveness of eculizumab treatment after kidney transplantation in patients with atypical haemolytic uraemic syndrome"],"prefix":"10.1093","volume":"32","author":[{"given":"Jan AJG","family":"van den Brand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobien C","family":"Verhave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy M","family":"Adang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack FM","family":"Wetzels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,1,20]]},"reference":[{"key":"key\n\t\t\t\t20171221053456_gfw353C1","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1681\/ASN.V961126","article-title":"The pathogenesis and treatment of hemolytic uremic syndrome","volume":"9","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171221053456_gfw353C2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/ajt.12077","article-title":"Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20171221053456_gfw353C3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171221053456_gfw353C4","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171221053456_gfw353C5","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1111\/j.1600-6143.2012.04252.x","article-title":"Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation","volume":"12","year":"2012","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20171221053456_gfw353C6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/j.ajkd.2015.04.010","article-title":"Discontinuation of eculizumab treatment in atypical hemolytic uremic syndrome: an update","volume":"66","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20171221053456_gfw353C7","volume-title":"Eculizumab for treating atypical haemolytic uraemic syndrome","author":"National Institute for Health and Care Excellence","year":"2015"},{"key":"key\n\t\t\t\t20171221053456_gfw353C8","first-page":"342","article-title":"Living kidney transplantation in adult patients with atypical haemolytic uraemic syndrome","volume":"71","year":"2013","journal-title":"Neth J Med"},{"key":"key\n\t\t\t\t20171221053456_gfw353C9","volume-title":"ERA-EDTA Registry Annual Report 2013","author":"ERA-EDTA Registry","year":"2015"},{"key":"key\n\t\t\t\t20171221053456_gfw353C10","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ki.2014.423","article-title":"Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies","volume":"87","year":"2015","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20171221053456_gfw353C11","doi-asserted-by":"crossref","first-page":"e1001307","DOI":"10.1371\/journal.pmed.1001307","article-title":"A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments","volume":"9","year":"2012","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20171221053456_gfw353C12","article-title":"Consumer Price Index","author":"Statistics Netherlands"},{"key":"key\n\t\t\t\t20171221053456_gfw353C13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.ki.5002014","article-title":"Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands","volume":"71","year":"2007","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20171221053456_gfw353C14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1017\/S0266462312000062","article-title":"Update of the Dutch manual for costing in economic evaluations","volume":"28","year":"2012","journal-title":"Int J Technol Assess Health Care"},{"key":"key\n\t\t\t\t20171221053456_gfw353C15","article-title":"Average personal income","author":"Statistics Netherlands"},{"key":"key\n\t\t\t\t20171221053456_gfw353C16","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s11136-006-0045-5","article-title":"Social participation and employment status after kidney transplantation: a systematic review","volume":"15","year":"2006","journal-title":"Qual Life Res"},{"key":"key\n\t\t\t\t20171221053456_gfw353C17","article-title":"Life expectancy","author":"Statistics Netherlands"},{"key":"key\n\t\t\t\t20171221053456_gfw353C18","doi-asserted-by":"crossref","first-page":"d1766","DOI":"10.1136\/bmj.d1766","article-title":"Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting","volume":"342","year":"2011","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20171221053456_gfw353C19","volume-title":"Sensible and Sustainable Care","author":"Council for Public Health and Health Care to the Minister of Health Welfare and Sport","year":"2006"},{"key":"key\n\t\t\t\t20171221053456_gfw353C20","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/jth.12615","article-title":"Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome","volume":"12","year":"2014","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t20171221053456_gfw353C21","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1182\/blood-2014-09-600411","article-title":"Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS","volume":"125","year":"2015","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171221053456_gfw353C22","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1053\/j.ajkd.2015.02.326","article-title":"Soluble c5b-9 as a biomarker for complement activation in atypical hemolytic uremic syndrome","volume":"65","year":"2015","journal-title":"Am J Kidney Dis"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/32\/suppl_1\/i115\/23000570\/gfw353.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T11:18:45Z","timestamp":1658575125000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/32\/suppl_1\/i115\/2930799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,1]]},"references-count":22,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2017,1,20]]},"published-print":{"date-parts":[[2017,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfw353","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,1]]},"published":{"date-parts":[[2017,1,1]]}}}